Article Details
Retrieved on: 2025-03-17 19:24:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
“Nirsevimab, very exciting, also known as Beyfortus, is a monoclonal antibody. It is recommended for infants under the age of 8 months entering their ...
Article found on: www.contemporarypediatrics.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here